Gene Therapy Shows Retinal Repair in Dogs with Rare Vision Impairment

Michigan State University research demonstrates single-dose gene therapy can repair damaged retinas in whippet dogs with a specific genetic mutation, with effects lasting up to three years.

Michigan State University researchers published findings in *Molecular Therapy Advances* (2026) showing single-dose gene therapy successfully repaired retinas in whippet dogs with mutations in the CaBP4 gene. Treated dogs exhibited improved vision in low-light conditions after therapy, with structural improvements including expanded outer plexiform layers and matured synaptic ribbons in retinal cells. These neural repair effects persisted for up to three years. The CaBP4 gene deficiency causes vision impairment in both affected dog breeds and humans, though the condition is rare in both populations. This work represents a decade-long study focused on retinal conditions. Human application remains unverified despite researchers' confidence in translatability. The study does not address cost implications or human efficacy.

Source: ScienceAlert